Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Hayden

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Spine|April 7, 2007
Key factors in back disability prevention: a consensus panel on their impact and modifiabilityJaime Guzman, Jill Hayden, Andrea D Furlan, et al.
Implementation Science : IS|July 3, 2021
What behaviour change techniques have been used to improve adherence to evidence-based low back pain imaging?Amanda Hall, Helen Richmond, Andrea Pike, et al.
Cancer|June 16, 2010
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonographyN Lynn Henry, Jon A Jacobson, Mousumi Banerjee, et al.
Journal of Clinical Epidemiology|May 12, 2007
Low-back pain definitions in occupational studies were categorized for a meta-analysis using Delphi consensus methodsLauren E Griffith, Sheilah Hogg-Johnson, Donald C Cole, et al.
Journal of Manipulative and Physiological Therapeutics|November 13, 2016
The Treatment of Neck Pain-Associated Disorders and Whiplash-Associated Disorders: A Clinical Practice GuidelineAndré E Bussières, Gregory Stewart, Fadi Al-Zoubi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapyYan Jin, Daniel F Hayes, Lang Li, et al.
Menopause (New York, N.Y.)|May 21, 2009
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapyJulie L Otte, David Flockhart, Daniel Hayes, et al.
Breast Cancer Research and Treatment|May 13, 2019
Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapyJennifer Y Sheng, Amanda L Blackford, Aditya Bardia, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Spine|April 7, 2007
Key factors in back disability prevention: a consensus panel on their impact and modifiabilityJaime Guzman, Jill Hayden, Andrea D Furlan, et al.
Implementation Science : IS|July 3, 2021
What behaviour change techniques have been used to improve adherence to evidence-based low back pain imaging?Amanda Hall, Helen Richmond, Andrea Pike, et al.
Cancer|June 16, 2010
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonographyN Lynn Henry, Jon A Jacobson, Mousumi Banerjee, et al.
Journal of Clinical Epidemiology|May 12, 2007
Low-back pain definitions in occupational studies were categorized for a meta-analysis using Delphi consensus methodsLauren E Griffith, Sheilah Hogg-Johnson, Donald C Cole, et al.
Journal of Manipulative and Physiological Therapeutics|November 13, 2016
The Treatment of Neck Pain-Associated Disorders and Whiplash-Associated Disorders: A Clinical Practice GuidelineAndré E Bussières, Gregory Stewart, Fadi Al-Zoubi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2012
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancerN Lynn Henry, Faouzi Azzouz, Zereunesay Desta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2008
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapyYan Jin, Daniel F Hayes, Lang Li, et al.
Menopause (New York, N.Y.)|May 21, 2009
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapyJulie L Otte, David Flockhart, Daniel Hayes, et al.
Breast Cancer Research and Treatment|May 13, 2019
Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapyJennifer Y Sheng, Amanda L Blackford, Aditya Bardia, et al.
Breast Cancer Research and Treatment|October 9, 2007
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitorsN Lynn Henry, Jon T Giles, Dennis Ang, et al.
Pageof 4